404
Nebulizer Devices Market Size & Share Analysis
Nebulizer Devices Market Size, Share, Dynamics, & Forecast Analysis- 2023-2028.
The report on the Nebulizer Devices Market is segmented by Type (Jet, Ultrasound, Mesh), By End-Use (Hospital and clinics, Emergency Centers, Home Healthcare), and by Region. It also focuses on the COVID-19 Impact Analysis and Forecast to 2028....
The nebulizer devices market size is expected to reach USD 1.62 billion in 2028.
The automotive fuel systems market was estimated at USD 1.13 billion in 2022.
The nebulizer devices market is expected to grow at an impressive CAGR of 6% in the coming years.
Nebulizers are respiratory drug delivery therapeutic device that helps to transform the liquid drug into aerosols or mist and delivers it directly to the lungs. The nebulization technique is commonly used to treat respiratory diseases such as cystic fibrosis, asthma, and chronic obstructive pulmonary disease (COPD). These devices are electrically powered and rechargeable. Nebulizers are specifically used to deliver liquid medication to breathing passage, thus reducing the bulging of the mucous membrane caused by pollutants.
Agilent Technologies, Inc. (The U.S), Allied Healthcare Products, Inc. (The U.S), CareFusion Corporation (The U.S), Covidien plc (Ireland), GE Healthcare (The U.S), GF Health Products Inc. (The U.S), Omron Healthcare, Inc. (Japan), PARI GmbH (Germany), Koninklijke Philips N.V. (Netherlands) and Briggs Healthcare (The U.S) are among the key players in the market.
The North American market garnered the highest market share of more than 25% in 2022
A rise in environmental pollution and a surge in the number of smokers, rising of chronic respiratory diseases, the growing geriatric population, and increasing demand for home-based healthcare devices are the factors driving the growth of the market.
Nebulizer devices companies, Hospitals, R&D organizations, Respiratory devices manufacturing companies, and Government organizations are the target audience in the market.